Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

[1]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[2]  A. Kastrati,et al.  Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. , 2009, European heart journal.

[3]  D. Capodanno,et al.  Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease , 2009, Circulation. Cardiovascular interventions.

[4]  F. Alfonso.  Left main coronary artery stenting: crossing the Rubicon. , 2009, Journal of the American College of Cardiology.

[5]  A. Kastrati,et al.  Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. , 2009, Journal of the American College of Cardiology.

[6]  S. de Servi,et al.  Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. , 2009, European heart journal.

[7]  F. Verheugt,et al.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. , 2009, Journal of the American College of Cardiology.

[8]  Young-Hak Kim,et al.  Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis , 2009, Circulation. Cardiovascular interventions.

[9]  S. de Servi,et al.  Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. , 2009, Journal of the American College of Cardiology.

[10]  P. Fitzgerald,et al.  9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. , 2009, Journal of the American College of Cardiology.

[11]  P. Teirstein.  Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis , 2009, Circulation.

[12]  Craig R. Smith.  Surgery, not percutaneous revascularization, is the preferred strategy for patients with significant left main coronary stenosis. , 2009, Circulation.

[13]  Y. Hayashi,et al.  Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation , 2009, Circulation.

[14]  J. Spertus,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Th , 2009, Journal of the American College of Cardiology.

[15]  D. Angiolillo,et al.  CORONARY ARTERY DISEASE Original Studies Long-Term Clinical Outcomes After Drug-Eluting Stent Implantation in Unprotected Left Main Coronary Artery Disease , 2009 .

[16]  Seung‐Jung Park,et al.  Percutaneous Coronary Intervention With Stent Implantation Versus Coronary Artery Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Is It Time to Change Guidelines? , 2009, Circulation. Cardiovascular interventions.

[17]  S. de Servi,et al.  Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. , 2009, The American journal of cardiology.

[18]  J. Dery,et al.  Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians , 2008, Circulation.

[19]  S. de Servi,et al.  Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents , 2008, Circulation. Cardiovascular interventions.

[20]  S. de Servi,et al.  Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. , 2008, The American journal of cardiology.

[21]  E. Hannan,et al.  Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery. , 2008, The Annals of thoracic surgery.

[22]  Seung‐Jung Park,et al.  Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. , 2008, JACC. Cardiovascular interventions.

[23]  P. Serruys,et al.  Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. , 2008, European heart journal.

[24]  I. Palacios,et al.  Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease The DELFT ( Drug Eluting stent for LeFT main ) Registry , 2008 .

[25]  I. Liu,et al.  Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. , 2008, Journal of the American College of Cardiology.

[26]  C. Chu,et al.  Percutaneous coronary intervention versus coronary artery bypass graft surgery for the treatment of unprotected left main coronary artery stenosis: in-hospital and one year outcome after emergent and elective treatments. , 2008, International heart journal.

[27]  C. Chu,et al.  Percutaneous coronary intervention versus coronary artery bypass graft surgery for the treatment of unprotected left main coronary artery stenosis: in-hospital and one year outcome after emergent and elective treatments. , 2008, International heart journal.

[28]  Young-Hak Kim,et al.  Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.

[29]  G. Stone,et al.  Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. , 2008, The American journal of cardiology.

[30]  S. Yusuf,et al.  Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. , 2008, Journal of the American College of Cardiology.

[31]  S. Qiao,et al.  Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation. , 2008, American heart journal.

[32]  D. Dudek,et al.  Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.

[33]  P. Teirstein,et al.  A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. , 2008, American heart journal.

[34]  S. Ellis,et al.  Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. , 2008, The American journal of cardiology.

[35]  H. Huikuri,et al.  Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting , 2008, Annals of medicine.

[36]  S. de Servi,et al.  A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). , 2007, European heart journal.

[37]  A. Íñiguez,et al.  Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. , 2007, The American journal of cardiology.

[38]  A. Colombo,et al.  Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment , 2007, Circulation.

[39]  A. Erglis,et al.  A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. , 2007, Journal of the American College of Cardiology.

[40]  P. Serruys,et al.  Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry , 2007, Circulation.

[41]  David B Matchar,et al.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.

[42]  Seung‐Jung Park,et al.  EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. , 2006, The American journal of cardiology.

[43]  G. Trevi,et al.  Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosis. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[44]  P. Serruys,et al.  Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam C , 2006, American heart journal.

[45]  I. Iakovou,et al.  Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. , 2006, American heart journal.

[46]  W. B. Meijboom,et al.  Multislice Spiral Computed Tomography for the Evaluation of Stent Patency After Left Main Coronary Artery Stenting: A Comparison With Conventional Coronary Angiography and Intravascular Ultrasound , 2006, Circulation.

[47]  G. Parodi,et al.  Drug‐eluting stent supported percutaneous coronary intervention for unprotected left main disease , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[48]  A. Branzi,et al.  Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). , 2006, The American journal of cardiology.

[49]  Seung‐Jung Park,et al.  Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. , 2006, The American journal of cardiology.

[50]  O. Alfieri,et al.  Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience , 2006, Circulation.

[51]  P. Serruys,et al.  Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Sten , 2006, Journal of the American College of Cardiology.

[52]  Ya‐Ling Han,et al.  Efficacy of stenting for unprotected left main coronary artery disease in 297 patients. , 2006, Chinese medical journal.

[53]  P. Teirstein,et al.  Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. , 2006, Journal of the American College of Cardiology.

[54]  P. Shah,et al.  Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.

[55]  H. Bøtker,et al.  Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[56]  T. Lhermusier,et al.  Clinical and angiographic outcome of paclitaxel-eluting stent implantation for unprotected left main coronary artery bifurcation narrowing. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[57]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[58]  Seung‐Jung Park.  Inflammatory biomarkers for prediction of outcomes after unprotected left main coronary intervention. , 2005, Circulation.

[59]  A. Branzi,et al.  Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis , 2005, Circulation.

[60]  Byung Ok Kim,et al.  Sirolimus- versus Paclitaxel-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis , 2005, Cardiology.

[61]  W. J. van der Giessen,et al.  The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. , 2005, Journal of the American College of Cardiology.

[62]  R. Califf.  Stenting or surgery: an opportunity to do it right. , 2005, Journal of the American College of Cardiology.

[63]  J. Schneider,et al.  Technique of left main stenting is dependent on lesion location and distal branch protection , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[64]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[65]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[66]  P. Serruys,et al.  Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH) , 2005, Circulation.

[67]  P. Serruys,et al.  Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. , 2005, The American journal of cardiology.

[68]  I. Iakovou,et al.  Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.

[69]  Seung‐Jung Park,et al.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.

[70]  M. Leesar,et al.  Correlations Between Fractional Flow Reserve and Intravascular Ultrasound in Patients With an Ambiguous Left Main Coronary Artery Stenosis , 2004, Circulation.

[71]  M. Pan,et al.  Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. , 2004, American heart journal.

[72]  J. Koolen,et al.  Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease , 2001, Heart.

[73]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[74]  A. Bernstein,et al.  A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.

[75]  J. Fajadet,et al.  Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents--results of the multicentre FRIEND registry. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[76]  Frederick A. Masoudi,et al.  ACCF/SCAI/STS/MTS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. Commentary , 2009 .

[77]  Joseph P Ornato,et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Journal of the American College of Cardiology.

[78]  S. Nashef,et al.  Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .

[79]  R. Califf,et al.  Technical feasibility , safety , and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing , 2022 .